Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$271,386,190
+$44,773,137 QoQ
Shares Held
1,078,470
+3.5% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#126
of 4,145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STOREBRAND ASSET MANAGEMENT AS holds $1,607,022,504 across 10 Drug Manufacturers - General names. ABBV ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
471,742 | $565,821,554 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,078,470 | $271,386,190 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,685,911 | $216,639,563 | |
| 4 | PFE |
Pfizer Inc
|
5,190,196 | $124,979,919 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
939,277 | $118,668,256 | |
| 6 | AMGN |
Amgen Inc
|
325,992 | $118,048,223 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,753,508 | $101,037,130 | |
| 8 | JNJ |
Johnson & Johnson
|
342,270 | $86,926,311 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $271,386,190 | 1,078,470 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $226,613,053 | 1,041,947 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $240,508,574 | 1,052,600 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $239,634,406 | 1,034,959 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $188,131,438 | 1,013,530 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $210,702,949 | 1,005,646 | Shares | Sole | 2026-06-03 | |
| 2024-12-31 | $185,818,579 | 1,045,687 | Shares | Sole | 2026-06-17 | |
| 2024-09-30 | $196,958,060 | 997,357 | Shares | Sole | 2026-06-17 | |
| 2024-06-30 | $166,914,516 | 973,149 | Shares | Sole | 2026-06-17 | |
| 2024-03-31 | $182,106,919 | 1,000,038 | Shares | Sole | 2026-06-17 | |
| 2023-12-31 | $153,675,690 | 991,648 | Shares | Sole | 2026-06-18 | |
| 2023-09-30 | $137,582,678 | 923,002 | Shares | Sole | 2026-06-18 | |
| 2023-06-30 | $124,808,348 | 926,359 | Shares | Sole | 2026-06-18 | |
| 2023-03-31 | $143,658,189 | 901,413 | Shares | Sole | 2026-06-18 | |
| 2022-12-31 | $153,833,973 | 951,884 | Shares | Sole | 2026-06-18 | |
| 2022-09-30 | $129,312,408 | 963,508 | Shares | Sole | 2026-06-18 | |
| 2022-06-30 | $150,554,901 | 982,991 | Shares | Sole | 2026-06-18 | |
| 2022-03-31 | $143,621,192 | 885,949 | Shares | Sole | 2026-06-18 | |
| 2021-12-31 | $113,341,986 | 837,090 | Shares | Sole | 2026-06-18 | |
| 2021-09-30 | $88,985,738 | 824,935 | Shares | Sole | 2026-06-18 | |
| 2021-06-30 | $92,695,511 | 822,936 | Shares | Sole | 2026-06-18 | |
| 2021-03-31 | $86,849,904 | 802,531 | Shares | Sole | 2026-06-18 | |
| 2020-12-31 | $81,132,479 | 757,186 | Shares | Sole | 2026-06-18 | |
| 2020-09-30 | $63,896,116 | 729,491 | Shares | Sole | 2026-06-18 | |
| 2020-06-30 | $65,789,534 | 670,091 | Shares | Sole | 2026-06-18 | |
| 2020-03-31 | $39,430,382 | 517,527 | Shares | Sole | 2026-06-18 | |
| No filing history on record for this holder in this stock. | ||||||